Form CMS-10431 Oncology Care Measures Online Data Entry Tool

PPS-Exempt Cancer Hospital Quality Reporting (PCHQR) Program

Web-Based Measures for Clinical Process/Oncology Care Measures
Online Data Entry Tool Content for FY2016 and Subsequent Years
(NQF 0380) Multiple Myeloma-Treatment with Bisphosphonates
Q1

Q2

Q3

Q4

NUMERATOR
Patients who were prescribed or
received intravenous
bisphosphonate therapy within the
12 month reporting period.

DENOMINATOR
All patients aged 18 years and
older with a diagnosis of multiple
myeloma, not in remission

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS
(NQF 0382) Oncology-Radiation Dose Limits to Normal Tissues
Q1

Q2

Q3

Q4

NUMERATOR
Patients who had documentation in
medical record that radiation dose
limits to normal tissues were
established prior to the initiation of
a course of 3D conformal radiation
for a minimum of two tissues

DENOMINATOR
All patients, regardless of age,
with a diagnosis of pancreatic or
lung cancer who receive 3D
conformal radiation therapy

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS

(NQF 0383) Oncology: Plan of Care for Pain
Q1

Q2

Q3

Q4

NUMERATOR
Patient visits that included a
documented plan of care to address
pain

DENOMINATOR
All visits for patients, regardless of
age, with a diagnosis of cancer
currently receiving chemotherapy
or radiation therapy who report
having pain

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS
(NQF 0384) Oncology: Pain Intensity Quantified
Q1

Q2

Q3

Q4

NUMERATOR
Patient visits in which pain
intensity is quantified

DENOMINATOR
All visits for patients, regardless of
age, with a diagnosis of cancer
currently receiving
chemotherapy or radiation therapy

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS

(NQF 0390) Prostate Cancer-Adjuvant Hormonal Therapy for High-Risk Patients
Q1

Q2

Q3

Q4

NUMERATOR
Patients who were prescribed
adjuvant hormonal therapy (GnRH
[gonadotropin-releasing hormone]
agonist or antagonist)

DENOMINATOR
All patients, regardless of age,
with a diagnosis of prostate cancer,
at high risk of recurrence,
receiving external beam
radiotherapy to the prostate

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS
(NQF 0389) Prostate Cancer-Avoidance of Overuse Measure-Bone Scan for Staging Low-Risk
Patients
Q1

Q2

Q3

Q4

NUMERATOR
Patients who did not have a bone
scan performed at any time since
diagnosis of prostate cancer

DENOMINATOR
Documentation of medical
reason(s) for having a bone scan
performed

Percent of Total
Please refer to specifications on the PQRS web site: http://www.cms.gov/Medicare/Quality-InitiativesPatient-Assessment-Instruments/PQRS/index.html?redirect=/PQRS
PRA Disclosure Statement
According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control
number for this information collection is 0938-XXXX . The time required to complete this information collection is estimated to average 10 minutes per response, including the time to review
instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or
suggestions for improving this form, please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C4-26-05, Baltimore, Maryland 21244-1850.